Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Showing 20 of 0 results

Not applicableStudy completedNCT00936351
What this trial is testing

Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders
US Department of Veterans Affairs 34
Not applicableStudy completedNCT01492439
What this trial is testing

Effectiveness of Cognitive Remediation in a Supported Education Setting

Who this might be right for
Psychosis
Centre for Addiction and Mental Health 37
Not applicableStudy completedNCT04191200
What this trial is testing

Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital

Who this might be right for
Dental DiseasesSchizophrenia
Centre Hospitalier Charles Perrens, Bordeaux 51
Not applicableUnknownNCT00006195
What this trial is testing

Glucose Regulation During Risperidone and Olanzapine Treatment

Who this might be right for
Schizophrenia
National Center for Research Resources (NCRR)
Large-scale testing (Phase 3)Study completedNCT00600756
What this trial is testing

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

Who this might be right for
Schizophrenic Disorders
AstraZeneca 798
Post-approval studies (Phase 4)Study completedNCT03323437
What this trial is testing

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

Who this might be right for
Schizophrenia Spectrum and Other Psychotic Disorders
Weill Medical College of Cornell University 26
Large-scale testing (Phase 3)Study completedNCT00523445
What this trial is testing

The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Inje University 120
Not applicableStudy completedNCT01399112
What this trial is testing

A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis

Who this might be right for
SmokingPsychosis
Northwell Health 11
Not applicableStudy completedNCT06723977
What this trial is testing

Effect of Simulation on Emotional Expression and Perceived Family Burden of Caregivers

Who this might be right for
SchizophreniaCaregiver BurdenExpressed Emotion
Eskisehir Osmangazi University 40
Not applicableStudy completedNCT01701609
What this trial is testing

Cognitive Remediation Therapy (CRT) in Adolescents With EOS

Who this might be right for
Schizophrenia
Hospital Clinic of Barcelona 50
Not applicableLooking for participantsNCT01409109
What this trial is testing

Database Registry for Neural Network Biomarkers in Psychosis

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Texas Southwestern Medical Center 1,000
Not applicableActive Not RecruitingNCT06487195
What this trial is testing

Effects of a Peer-facilitated, Recovery-focused Self-illness Management Program for First-episode Psychosis

Who this might be right for
Psychotic Disorders
Chinese University of Hong Kong 198
Testing effectiveness (Phase 2)UnknownNCT01474395
What this trial is testing

N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Nathan Kline Institute for Psychiatric Research 16
Large-scale testing (Phase 3)Ended earlyNCT02261519
What this trial is testing

Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 280
Large-scale testing (Phase 3)Study completedNCT00843687
What this trial is testing

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Not applicableStudy completedNCT00576095
What this trial is testing

Clinical and Biological Characteristics of Psychotic Depression

Who this might be right for
DepressionPsychotic DisordersDepressive Disorder, Major
Stanford University 73
Not applicableUnknownNCT05448430
What this trial is testing

ITBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.

Who this might be right for
Schizophrenia
Central South University 50
Testing effectiveness (Phase 2)Study completedNCT01548612
What this trial is testing

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Who this might be right for
Schizophrenia
University of Sao Paulo 20
Testing effectiveness (Phase 2)Study completedNCT00149292
What this trial is testing

Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo

Who this might be right for
Schizophrenia
Denovo Biopharma LLC 195
Not applicableLooking for participantsNCT07093671
What this trial is testing

Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P)

Who this might be right for
Psychosis
Marco Armando 212
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation